INTERACTION OF BIOACTIVE COMPOUNDS WITH CERAMIC MATERIALS – A REVIEW
-
Published:2022
Issue:2
Volume:7
Page:47-82
-
ISSN:2537-4761
-
Container-title:Annals of the Academy of Romanian Scientists Series on Physics and Chemistry
-
language:
-
Short-container-title:AnnalsARSciPhysChem
Author:
PALTINEAN Gertrud-Alexandra, ,Tomoaia Gheorghe,RACZ Levente-Zsolt,MOCANU Aurora,Tomoaia-Cotisel Maria, , , ,
Abstract
This review examines the interaction between silymarin (SIL) and other plant-based bioactive compounds such as curcumin (CCM), piperine (PIP), resveratrol (RES), and icariin (ICA). Their combination revealed synergistic effects on colon (HCT116), breast (T47D) tumor cells, hepatocellular carcinoma, and periodontal disease. The review also addresses the interaction between these plant extracts with ceramic materials such as hydroxyapatite (HAP) and carotenoids with concrete examples of biomedical applications. Silymarin’s interaction with chemotherapeutic drugs (doxorubicin-DOX, paclitaxel-PCT and 5-Fluorouracil-5-FLU) and gold nanoparticles-GNPs and silver nanoparticles-SNPs is also debated. All these combinations can form composites of major importance in the biomedical field and to contribute significantly to orthopedic surgery where materials are needed for implants that face severe infections. This short review highlights the variety of multifunctional nanoparticles that open new opportunities in cancer treatment and the need to use the Langmuir Blodgett Technique that mimics the biological membrane and provides rich medical information.
Publisher
Academia Oamenilor de Stiinta din Romania
Reference216 articles.
1. [1] G.-A. Paltinean, S. Riga, Gh. Tomoaia, A. Mocanu, M. Tomoaia-Cotisel, Bioactive Compounds from Plants Used as Therapeutic Agents in Biomedical Applications - A Literature Review, Academy of Romanian Scientists, Annals Series on Biological Sciences, 10(2), 103-141 (2021). 2. [2] Y. J. Surh, S. S. Han, Y. S. Keum, H. J. Seo, S. S. Lee, Inhibitory effects of curcumin and capsaicin on phorbol ester-induced activation of eukaryotic transcription factors, NF-kappaB and AP-1, Biofactors, 12(1-4), 107-112 (2000). 3. [3] T. Dorai, Y. C. Cao, B. Dorai, R. Buttyan, A. E. Katz, Therapeutic potential of curcumin in human prostate cancer. III. Curcumin inhibits proliferation, induces apoptosis, and inhibits angiogenesis of LNCaP prostate cancer cells in vivo, Prostate, 47(4), 293-303 (2001). 4. [4] S. Garg, A. Garg, Encapsulation of curcumin in silver nanoparticle for enhancement of anticancer drug delivery, Int. J. Pharm. Sci. Res., 9(3), 1160-1166 (2018). 5. [5] D. Perrone, F. Ardito, G. Giannatempo, M. Dioguardi, G. Troiano, L. Lo Russo, A. De Lillo, L. Laino, L. Lo Muzio, Biological and therapeutic activities, and anticancer properties of curcumin (Review), Exp. Ther. Med., 10, 1615-1623 (2015).
|
|